Modeling BCMA-Specific Regulated CAR T Cells to Target Long-Lived Plasma Cells or Multiple Myeloma

被引：0
|
作者：
Jacobs, Chester [1 ,2 ]
Honaker, Yuchi [1 ,2 ]
Leung, Wai-Hang [3 ]
Stoffers, Claire [1 ,2 ]
Cheng, Rene [1 ,2 ]
English, Jeb [1 ,2 ]
Sommer, Karen [1 ,2 ]
Khan, Iram [1 ,2 ]
James, Richard [1 ,2 ,4 ,5 ]
Astrakhan, Alexander [3 ]
Rawlings, David J. [1 ,2 ,4 ,5 ]
机构：
[1] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA
[2] Seattle Childrens Res Inst, Program Cell & Gene Therapy, Seattle, WA USA
[3] Bluebird Bio Inc, Cambridge, MA USA
[4] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA
[5] Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
366
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [21] Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma
    Da Via, Matteo C.
    Dietrich, Oliver
    Truger, Marietta
    Arampatzi, Panagiota
    Duell, Johannes
    Heidemeier, Anke
    Zhou, Xiang
    Danhof, Sophia
    Kraus, Sabrina
    Chatterjee, Manik
    Meggendorfer, Manja
    Twardziok, Sven
    Goebeler, Maria-Elisabeth
    Topp, Max S.
    Hudecek, Michael
    Prommersberger, Sabrina
    Hege, Kristen
    Kaiser, Shari
    Fuhr, Viktoria
    Weinhold, Niels
    Rosenwald, Andreas
    Erhard, Florian
    Haferlach, Claudia
    Einsele, Hermann
    Kortuem, K. Martin
    Saliba, Antoine-Emmanuel
    Rasche, Leo
    NATURE MEDICINE, 2021, 27 (04) : 616 - 619
  • [22] BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions
    Sun, Fumou
    Cheng, Yan
    Chen, Jin-Ran
    Wanchai, Visanu
    Mery, David E.
    Xu, Hongwei
    Gai, Dongzheng
    Al Hadidi, Samer
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    van Rhee, Frits
    Tricot, Guido
    Shaughnessy, John D., Jr.
    Zhan, Fenghuang
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (01):
  • [23] Efficacy and Safety of BCMA-Specific CAR T Cell-Based Therapy in Relapsed/Refractory Multiple Myeloma Patients with Extramedullary Disease
    Qi, Yuekun
    Qiao, Jianlin
    Li, Zhenyu
    Xu, Kailin
    BLOOD, 2023, 142
  • [24] Rejuvenated BCMA-specific CD8+Cytotoxic T lymphocytes derived from induced pluripotent stem cells for treatment of Multiple Myeloma
    Bae, Jooeun
    Kitayama, Shuichi
    Daheron, Laurence
    Herbert, Zach
    Munshi, Nikhil C.
    Ritz, Jerome
    Kaneko, Shin
    Anderson, Kenneth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S84 - S84
  • [25] Generation of human long-lived plasma cells by developmentally regulated epigenetic imprinting
    Joyner, Chester J.
    Ley, Ariel M.
    Nguyen, Doan C.
    Ali, Mohammad
    Corrado, Alessia
    Tipton, Christopher
    Scharer, Christopher D.
    Mi, Tian
    Woodruff, Matthew C.
    Hom, Jennifer
    Boss, Jeremy M.
    Duan, Meixue
    Gibson, Greg
    Roberts, Danielle
    Andrews, Joel
    Lonial, Sagar
    Sanz, Inaki
    Lee, F. Eun-Hyung
    LIFE SCIENCE ALLIANCE, 2022, 5 (03)
  • [26] Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth
    Zhang, Xi
    Ng, Yu Yang
    Du, Zhicheng
    Li, Zhendong
    Chen, Can
    Xiao, Lin
    Chng, Wee Joo
    Wang, Shu
    PLOS ONE, 2022, 17 (06):
  • [27] Immunotherapeutic application of induced pluripotent stem cell technology: Rejuvenated BCMA-specific CD8+T cells for multiple myeloma.
    Bae, Jooeun
    Kitayama, Shuichi
    Herbert, Zach
    Daheron, Laurence
    Munshi, Nikhil
    Kaneko, Shin
    Ritz, Jerome
    Anderson, Kenneth
    CANCER RESEARCH, 2022, 82 (12)
  • [28] Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells
    Mi, Jian-Qing
    Fan, Xiaohu
    Xu, Jie
    Liu, Yuanfang
    Zhuang, Yan
    Yang, Shuangshuang
    Zhang, Wu
    Chen, Bing
    Wang, Yueying
    Weng, Xiangqin
    Li, Junmin
    Fu, Weijun
    Jiang, Hua
    Zhu, Li
    Chen, Zhu
    Chen, Sai-Juan
    Hou, Jian
    BLOOD, 2017, 130
  • [29] Mouse long-lived plasma cells develop from multiple origins
    Nature Immunology, 2022, 23 : 1521 - 1522
  • [30] Mouse long-lived plasma cells develop from multiple origins
    Qi, Hai
    Liu, Xin
    NATURE IMMUNOLOGY, 2022, 23 (11) : 1521 - 1522
12345